The integration of artificial intelligence into healthcare is rapidly evolving from an experimental tool into a core operational and clinical necessity. Propelled by an exceptional 35.9% CAGR and a trajectory toward a $765 billion valuation by 2035, AI is fundamentally redefining pharmaceutical research, diagnostic precision, and administrative workflows. As specialized sub-segments like generative AI and clinical trial optimization scale globally—led by strong adoption in North America and surging IT modernization across Asia-Pacific—artificial intelligence will permanently reshape the speed, accuracy, and efficiency of modern medicine